Welcome to Roche Foundation Medicine.

This site is not intended to provide medical advice and/or treatment guidance. It is produced by Roche as a partner of Foundation Medicine.

Please select an option:

!
We use cookies to help provide you with a better service. You can change your cookie settings at any time. Otherwise, we will assume you're OK to continue.
×
Menu
Close
Roche Foundation Medicine Contact us

The Roche Foundation Medicine collaboration

Roche Foundation Medicine are collaborating to pioneer progress in precision medicine for cancer patients around the world

As part of our long-standing commitment to pioneering progress in precision medicine, molecular insights leader Foundation Medicine has become a member of the Roche Group. Thanks to Roche’s expertise and commitment in oncology and Foundation Medicine’s leading technology, validation and experience in cancer profiling, together we are:1

  • Increasing understanding of tumours and providing insights on clinical trials to consider, to enable smarter, more efficient research and development
  • Improving patient care by providing genomic insights with associated targeted therapies, immunotherapies and relevant clinical trials
Molecular understanding of cancer Help patients find clinical trials Help select treatment plans Database & Analytics interface R&D Collaboration Clinical Practice Collaboration Patient outcomes

Any questions? Any questions?
References
  1. Roche Media Release, 2018. Available at: https://www.roche.com/media/releases/med-cor-2018-06-19.htm (Accessed August 2020).